CIK 0001745999 · Large accelerated filer
Beam Therapeutics Inc.
Sign in to watch- Ticker
- BEAM
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 857-327-8775
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- Former names
- Beam Therapeutics Inc.
- 4 Gift 10% owner gave 1,232,434 shares (gift)
- 4 Planned sale SVP, Finance and Treasurer sold 467 shares at $24.53 ($11,456)
- 4 Planned sale Chief Legal Officer sold 373 shares at $24.53 ($9,150)
- 4 Planned sale CEO sold 50,000 shares at an average $24.57 ($1,228,323)
- 4 Open-market sale 10% owner sold 48,374 shares at $20.50 ($991,667)
- 4 Planned sale Chief Medical Officer sold 1,250 shares at an average $19.17 ($23,962)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Chief Legal Officer sold 5,674 shares at $18.35 ($104,122)
- 4 Planned sale CEO sold 30,663 shares at $18.35 ($562,684)
- 4 Planned sale President sold 7,434 shares at $18.35 ($136,418)
- 4 Planned sale SVP, Finance and Treasurer sold 3,015 shares at $18.35 ($55,330)
- 4 Planned sale Chief Medical Officer sold 30,563 shares at an average $17.92 ($547,835)
- 4 Grant or award Chief Legal Officer acquired 20,000 shares (grant or award)
Page 3 of 12 · 238 filings